A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NextPoint Therapeutics, Inc.
NextPoint Therapeutics, Inc.
Ascentage Pharma Group Inc.
Veana Therapeutics
DNAtrix, Inc.
SynCore Biotechnology Co., Ltd.
Bellicum Pharmaceuticals
QT Ultrasound LLC
Laser LabCorp
Seno Medical Instruments Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Diagnostic Photonics, Inc.
Mitra RxDx, Inc.
Envita Medical Center, Inc.